ethyl 4-chloro-5H-pyrrolo[3,2-d]pyrimidine-6-carboxylate, 97.0%, 250mg

Cyclopentan, min. 95 %, zur Synthese, 2.5 l, Glasverpackung

2-Nitro-4-(trifluoromethoxy)benzoic acid, 95%, 100mg

1-cyclopentyl-3-nitro-1H-pyrazole, 1g

6-METHOXYQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 1g

2-Methoxy-1-nitronaphthalene, 97%, 250mg

2-(p-Tolyl)benzo[d]thiazole, 95.0%, 1g

5-Bromoindan-2-ol, 95.0%, 1g

1-(diazyn-1-ium-1-yl)-24-hydroxy-4,7,10,13,16,19,22-heptaoxa-1-azatetracosan-1-ide, 97%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)pentanoic acid, 95.0%, 100g

5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine hydrochloride, 95.0%, 250mg

3-(Methylamino)quinazolin-4(3H)-one, 97%, 250mg

Methyl 6-chloro-2-fluoronicotinate, 95.0%, 25g